"Survival in head and neck cancer" trang 1 - tải miễn phí từ tailieunhanh
Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort

Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort
10    27    1
Rationale and design of LUX-Head & Neck 1: A randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy

Rationale and design of LUX-Head & Neck 1: A randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy
9    74    1
G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy

G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy
11    77    1
Tumor cells with low proteasome subunit expression predict overall survival in head and neck cancer patients

Tumor cells with low proteasome subunit expression predict overall survival in head and neck cancer patients
11    51    1
Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and nonoropharyngeal patients

Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and nonoropharyngeal patients
13    43    1
Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer

Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer
11    55    1
Impact of comprehensive geriatric assessment on survival, function, and nutritional status in elderly patients with head and neck cancer: Protocol for a multicentre randomised controlled trial (EGeSOR)

Impact of comprehensive geriatric assessment on survival, function, and nutritional status in elderly patients with head and neck cancer: Protocol for a multicentre randomised controlled trial (EGeSOR)
9    55    1
Treatment patterns of targeted and nontargeted therapies and survival effects in patients with locally advanced head and neck cancer in Taiwan

Treatment patterns of targeted and nontargeted therapies and survival effects in patients with locally advanced head and neck cancer in Taiwan
12    6    1
Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis

Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis
11    51    1
An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: Successive lines of active chemotherapeutic agents

An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: Successive lines of active chemotherapeutic agents
8    36    2
Prognostic role of DFNA5 in head and neck squamous cell carcinoma revealed by systematic expression analysis

Prognostic role of DFNA5 in head and neck squamous cell carcinoma revealed by systematic expression analysis
12    30    1
Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma

Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma
19    16    1
Different inflammatory blood markers correlate with specific outcomes in incident HPV‑negative head and neck squamous cell carcinoma: A retrospective cohort study

Different inflammatory blood markers correlate with specific outcomes in incident HPV‑negative head and neck squamous cell carcinoma: A retrospective cohort study
11    19    1
Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: Realworld data in Korea

Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: Realworld data in Korea
9    45    1
Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer

Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer
11    33    1
Association between cancer stem cell gene expression signatures and prognosis in head and neck squamous cell carcinoma

Association between cancer stem cell gene expression signatures and prognosis in head and neck squamous cell carcinoma
13    9    1
Comparing the characteristics and predicting the survival of patients with head and neck melanoma versus body melanoma: A population-based study

Comparing the characteristics and predicting the survival of patients with head and neck melanoma versus body melanoma: A population-based study
16    19    1
Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: A multicenter retrospective study from Japan

Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: A multicenter retrospective study from Japan
9    6    1
Can pattern and depth of invasion predict lymph node relapse and prognosis in tongue squamous cell carcinoma

Can pattern and depth of invasion predict lymph node relapse and prognosis in tongue squamous cell carcinoma
9    70    0
Effect of hypoxia on the expression of αB-crystallin in head and neck squamous cell carcinoma

Effect of hypoxia on the expression of αB-crystallin in head and neck squamous cell carcinoma
9    36    1